According to Futu News on September 11, clinical medical company$Relay Therapeutics (RLAY.US)$ It declined today. As of press release, the stock is now down 21.67% to $7.05, with a turnover of $33.1142 million.

According to the news, the company announced yesterday after the market that it will publicly issue 28,571,429 common shares at a price of $7 per share. In addition, the company also granted the underwriter a 30-day option, which can purchase an additional 4,285,714 shares of common stock, totaling approximately USD 0.2 billion in this public offering.

Goldman Sachs, TD Cowen, Stifel, and Bank of America will act as underwriters for this offering. According to customary closing conditions, the offering is expected to be completed around September 12, 2024.